Risk Stratification and Outcomes of Intracranial Hemorrhage in Patients with Immune Thrombocytopenia under 60 Years of Age
Peng Zhao,Ming Hou,Yi Liu,Hui-Xin Liu,Rui-Bin Huang,Hong-Xia Yao,Ting Niu,Jun Peng,Ming Jiang,Yan-Qiu Han,Jian-Da Hu,Hu Zhou,Ze-Ping Zhou,Lin Qiu,Lian-Sheng Zhang,Xin Wang,Hua-Quan Wang,Ru Feng,Lin-Hua Yang,Liang-Ming Ma,Shun-Qing Wang,Pei-Yan Kong,Wen-Sheng Wang,Hui-Ping Sun,Jing Sun,He-Bing Zhou,Tie-Nan Zhu,Li-Ru Wang,Jing-Yu Zhang,Qiu-Sha Huang,Xiao LiU,Hai-Xia Fu,Yue-Ying Li,Qian-Fei Wang,Qian Jiang,Hao Jiang,Jin Lu,Xiao-Hui Zhang
DOI: https://doi.org/10.1080/09537104.2020.1786042
2020-01-01
Platelets
Abstract:Intracranial hemorrhage (ICH) is a devastating complication of immune thrombocytopenia (ITP). However, information on ICH in ITP patients under the age of 60 years is limited, and no predictive tools are available in clinical practice. A total of 93 adult patients with ITP who developed ICH before 60 years of age were retrospectively identified from 2005 to 2019 by 27 centers in China. For each case, 2 controls matched by the time of ITP diagnosis and the duration of ITP were provided by the same center. Multivariate analysis identified head trauma (OR = 3.216, 95%CI 1.296-7.979,P=.012), a platelet count <= 15,000/mu L at the time of ITP diagnosis (OR = 1.679, 95%CI 1.044-2.698,P=.032) and severe/life-threatening bleeding (severe bleedingvs. mild bleeding, OR = 1.910, 95%CI 1.088-3.353,P=.024; life-threatening bleedingvs. mild bleeding, OR = 2.620, 95%CI 1.360-5.051,P=.004) as independent risk factors for ICH. Intraparenchymal hemorrhage (OR = 5.191, 95%CI 1.717-15.692,P=.004) and a history of severe bleeding (OR = 4.322, 95%CI 1.532-12.198,P=.006) were associated with the 30-day outcome of ICH. These findings may facilitate ICH risk stratification and outcome prediction in patients with ITP.